Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.
about
Interleukin-22 ameliorates acute severe pancreatitis-associated lung injury in miceInfluenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of DiseaseThe crystal structure of zebrafish IL-22 reveals an evolutionary, conserved structure highly similar to that of human IL-22The immunology of influenza virus-associated bacterial pneumoniaInfluenza vaccines to control influenza-associated bacterial infection: where do we stand?Why is coinfection with influenza virus and bacteria so difficult to control?Multiplex Analysis of Serum Cytokines in Humans with Hantavirus Pulmonary Syndrome.Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense.Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo.The oral commensal Streptococcus mitis shows a mixed memory Th cell signature that is similar to and cross-reactive with Streptococcus pneumoniae.PACAP38 differentially effects genes and CRMP2 protein expression in ischemic core and penumbra regions of permanent middle cerebral artery occlusion model mice brain.Tailored immune responses: novel effector helper T cell subsets in protective immunity.Interleukin-22: immunobiology and pathology.Emerging Role of Interleukin 22 in Hepatitis B Virus Infection: a Double-edged Sword.Lambda Interferon Restructures the Nasal Microbiome and Increases Susceptibility to Staphylococcus aureus SuperinfectionA pro-inflammatory role for Th22 cells in Helicobacter pylori-associated gastritis.A Toll-Like Receptor 5 Agonist Improves the Efficacy of Antibiotics in Treatment of Primary and Influenza Virus-Associated Pneumococcal Mouse Infections.TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfection.Epithelial-intrinsic IKKα expression regulates group 3 innate lymphoid cell responses and antibacterial immunity.IL-22 Defect During Streptococcus pneumoniae Infection Triggers Exacerbation of Chronic Obstructive Pulmonary DiseaseAttenuated Airway Epithelial Cell Interleukin-22R1 Expression in the Infant Nonhuman Primate Lung.MicroRNA-155 regulates host immune response to postviral bacterial pneumonia via IL-23/IL-17 pathway.The Role of IL-22 in Viral Infections: Paradigms and ParadoxesToll-like receptor 2-dependent protection against pneumococcal carriage by immunization with lipidated pneumococcal proteins.Conventional NK cells can produce IL-22 and promote host defense in Klebsiella pneumoniae pneumonia.Immune dysfunction and bacterial coinfections following influenza.Role of type 1 natural killer T cells in pulmonary immunity.Dysregulation in lung immunity - the protective and pathologic Th17 response in infection.A tale of two cytokines: IL-17 and IL-22 in asthma and infection.Therapeutic opportunities of the IL-22-IL-22R1 system.Immunomodulators targeting MARCO expression improve resistance to postinfluenza bacterial pneumonia.The inflammatory response triggered by Influenza virus: a two edged sword.Lung-resident γδ T cells and their roles in lung diseases.IL-17 in the lung: The Good, the Bad, and the Ugly.Influenza Casts a Lung Shadow.IL-22 exacerbates weight loss in a murine model of chronic pulmonary Pseudomonas aeruginosa infectionInfluenza A virus-induced release of interleukin-10 inhibits the anti-microbial activities of invariant natural killer T cells during invasive pneumococcal superinfection.Interleukin-22 protects against non-typeable Haemophilus influenzae infection: alteration during chronic obstructive pulmonary disease.Examining the Effects of External or Internal Radiation Exposure of Juvenile Mice on Late Morbidity after Infection with Influenza A.Innate Lymphoid Cells Are the Predominant Source of IL-17A during the Early Pathogenesis of Acute Respiratory Distress Syndrome.
P2860
Q24658609-5B2C32C6-D28B-4E86-8B78-C1578FDA3D6FQ26799132-42F55F4B-5F1B-46E3-9D18-CB6216CED9F8Q27690244-5BF15E06-857E-46D4-9291-8CC901455D60Q28084679-1244500B-F769-4D08-9067-8C839F0632DFQ30366650-07BF8A89-3452-4C69-877D-2A3A0F526C73Q30371269-0DC011EA-337B-4C5F-8D7B-767AFC463E34Q33425939-72B80854-83F5-4372-BA50-208D495F61BAQ33788735-124AF65E-1A7F-4F50-9CC2-389E055FD8BCQ33797498-F8D1CFC8-71C8-4A30-AF7B-14C9AFCE20D7Q34041104-0AEFD34A-541D-45CE-890C-D3F2D4B00F64Q34358768-6518E7C0-E3DB-4E09-9E42-7A97BB0646F7Q35105613-9420FC15-6E74-4701-B114-63D7D066623EQ35530956-591B481B-3CC8-4403-B2FE-157176262202Q35906051-9A038CDB-326E-4248-A15B-EF57573A551AQ35918826-0ABFEB87-122B-466F-AF65-41A59C57A894Q36005402-449A4251-289A-4CF8-8989-30C1D83842BBQ36075829-40A22638-3E80-4FB8-94C5-C710DB4B8AAFQ36078577-157528DB-A9A6-45DE-ABF2-6FDA8EF41355Q36080691-D692FC9C-8726-4161-84D1-43D82E81B15CQ36540978-CD5B3E7E-9F5B-466E-AE95-0E49B6058033Q36549105-BDA4DE85-4E3D-42FD-8339-4E3465F499B2Q36638477-784A568D-7F32-4AB9-9600-633803D99F7CQ36947949-8FA4D11D-0785-48E4-9FF7-1119DD855799Q37713348-3D6A6694-DFE7-4C82-BA7E-372FEE82FAE7Q37716155-75154692-C648-46DC-8524-758967ACBF68Q38130488-F83F7EA4-ACA9-4D12-BF6D-A0D77600E515Q38150638-C6CAC52E-E8F8-4277-BB5A-5E1C83BF0EB7Q38153014-0B61D8B1-ACCE-42BD-95EF-D4E870A9373FQ38170180-1525B227-5FE8-4DA8-9BC9-2B6DEDDF1B43Q38174792-E9ECCFFE-4124-4157-8365-E73C51A809D3Q38707767-5281CAE6-280A-492C-AA81-33A9C1AB609BQ38981754-FB4570E0-D8F1-49F4-893F-5394DC6D8CE9Q39337563-18F9CD50-A197-40F1-9D75-6380B5B82235Q40062327-678BF87F-4EDA-4E5B-ACD5-8F21825CC1C1Q40323689-01A9E313-B6AF-4101-973A-82DFCFF6A78CQ40626615-B8E23036-37B9-4CA6-A8D8-5A45EEE6BC65Q40661474-41C93B3C-9F65-4DF9-B073-9A35F93EEB9DQ40688717-977CD4D5-8A59-4CD4-BF02-AA727A1DADD4Q40794291-8FDBFFE8-BDA7-4D70-8AAB-4E30171AFB0CQ40942694-4747A93B-37DA-4FFA-BACB-D2BC0F25BD93
P2860
Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Interleukin-22 reduces lung in ...... secondary bacterial infection.
@en
type
label
Interleukin-22 reduces lung in ...... secondary bacterial infection.
@en
prefLabel
Interleukin-22 reduces lung in ...... secondary bacterial infection.
@en
P2093
P2860
P50
P356
P1433
P1476
Interleukin-22 reduces lung in ...... secondary bacterial infection
@en
P2093
Adeline Barthelemy
Carl De Trez
Elodie Macho Fernandez
Fany Blanc
François Trottein
Joelle Renneson
Josette Fontaine
Laure Dumoutier
Michel-René Huerre
Pierre Gosset
P2860
P304
P356
10.1128/JVI.02943-12
P407
P50
P577
2013-04-17T00:00:00Z